Streetbeat News

Analyst Ratings

CHGG

JP Morgan analyst Doug Anmuth maintains a Neutral rating on Chegg (NYSE:CHGG) and raises the price target from $12 to $14.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 08, 2023 | 12:57 pm

SAGE

Goldman Sachs analyst Salveen Richter has downgraded Sage Therapeutics from Buy to Neutral and set a price target of $22.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 12:56 pm

PARA

JP Morgan analyst Philip Cusick maintains an Underweight rating on Paramount Global (NASDAQ:PARA) and raises the price target from $16 to $17.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 08, 2023 | 12:55 pm

SOVO

Stephens & Co. analyst Jim Salera has downgraded Sovos Brands (NASDAQ:SOVO) from Overweight to Equal-Weight and set a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 12:54 pm

KRC

B of A Securities analyst James Feldman has downgraded Kilroy Realty (NYSE:KRC) from Buy to Neutral.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 12:52 pm

VNO

B of A Securities analyst Camille Bonnel maintains a Neutral rating on Vornado Realty (NYSE:VNO) and raises the price target from $18 to $24.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 08, 2023 | 12:52 pm

DEI

B of A Securities analyst James Feldman has downgraded Douglas Emmett (NYSE:DEI) from Neutral to Underperform and lowered the price target from $12 to $10.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 12:51 pm

FGEN

B of A Securities analyst Jason Gerberry has downgraded FibroGen (NASDAQ:FGEN) from Neutral to Underperform and lowered the price target from $4 to $2.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 12:49 pm

SLG

B of A Securities analyst James Feldman maintains a Neutral rating on SL Green Realty (NYSE:SLG) and raises the price target from $27 to $36.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 08, 2023 | 12:49 pm

AYX

Loop Capital analyst Yun Kim has downgraded Alteryx (NYSE:AYX) from Buy to Hold and lowered the price target from $65 to $30.

Portfolio Pulse from richadhand@benzinga.com

August 08, 2023 | 12:48 pm